WT Wealth Management Has $5.08 Million Stock Position in VanEck Pharmaceutical ETF (NASDAQ:PPH)

WT Wealth Management lifted its position in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 6.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 53,660 shares of the company’s stock after buying an additional 3,424 shares during the quarter. VanEck Pharmaceutical ETF comprises approximately 1.2% of WT Wealth Management’s holdings, making the stock its 19th biggest position. WT Wealth Management’s holdings in VanEck Pharmaceutical ETF were worth $5,080,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in PPH. Comerica Bank grew its position in shares of VanEck Pharmaceutical ETF by 39.4% during the 1st quarter. Comerica Bank now owns 1,337 shares of the company’s stock worth $121,000 after purchasing an additional 378 shares in the last quarter. Renaissance Technologies LLC lifted its position in shares of VanEck Pharmaceutical ETF by 85.0% during the 2nd quarter. Renaissance Technologies LLC now owns 25,900 shares of the company’s stock worth $2,369,000 after buying an additional 11,902 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its position in VanEck Pharmaceutical ETF by 1.7% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 160,039 shares of the company’s stock valued at $14,641,000 after acquiring an additional 2,694 shares during the last quarter. CWM LLC acquired a new position in VanEck Pharmaceutical ETF during the second quarter worth about $55,000. Finally, Envestnet Portfolio Solutions Inc. bought a new position in shares of VanEck Pharmaceutical ETF in the second quarter worth about $211,000.

VanEck Pharmaceutical ETF Stock Performance

Shares of PPH traded down $0.02 during mid-day trading on Tuesday, reaching $93.61. The company had a trading volume of 136,234 shares, compared to its average volume of 139,085. The company has a market capitalization of $719.86 million, a price-to-earnings ratio of 21.04 and a beta of 0.72. The company’s 50 day simple moving average is $96.22 and its 200 day simple moving average is $92.47. VanEck Pharmaceutical ETF has a 1-year low of $74.05 and a 1-year high of $99.51.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.